Evogene Ltd (NASDAQ:EVGN) price closed higher on current market day and jumping 100.00% above its previous close.
A look at the daily price movement shows that the last close reads $1.13. Taking into account the 52-week price action we note that the stock hit a 52-week high of $7.19 and 52-week low of $0.95. The stock added 99.56% on its value in the past month.
Here is a look at the average analyst rating for the stock as represented on a scale of 1.00 to 5.00, with the extremes of 1.00 and 5.00 suggesting the stock is strong buy or strong sell respectively. Specifically, 7 analysts have assigned EVGN a recommendation rating as follows: 1 rate it as a Hold; 5 advise Buy while 1 analyst(s) assign an Overweight rating. 0 analyst(s) have tagged the Evogene Ltd (EVGN) stock as Underweight, with 0 recommending Sell. In general, analysts have rated the stock Buy, a scenario likely to bolster investors out for an opportunity to add to their holdings of the company’s shares.
The overview shows that EVGN’s price is at present 84.81% off the SMA20 and 94.04% from the SMA50. The Relative Strength Index (RSI) metric on the 14-day timeframe is pointing at 87.86, with weekly volatility standing at 34.39%. The indicator jumps to 15.88% when calculated based on the past 30 days. Evogene Ltd (NASDAQ:EVGN)’s beta value is holding at 1.55, while the average true range (ATR) indicator is currently reading 0.16. Considering analysts have assigned the stock a price target range of $3.5-$3.5 as the low and high respectively, we find the trailing 12-month average consensus price target to be $3.5. Based on this estimate, we see that current price is roughly -54.87% off the estimated low and -54.87% off the forecast high. Investors will no doubt be excited to see the share price fall to $3.5, which is the median consensus price, and at that level EVGN would be -54.87% from current price.
Current records show that the company has 6.67M in outstanding shares. The insiders’ percentage holdings are 1.56% of outstanding shares while the percentage share held by institutions stands at 7.62%. But the 20.86% upside, the stock’s price has registered year-to-date as of last trading, will likely reignite investor interest given the prospect of it rallying even higher.
